Skip to main content

West Pharmaceutical Services, Inc.

corporate_fare Company Profile

West Pharmaceutical Services, Inc.

WST·NYSE·Industrial Applications And Services·CIK 0000105770

WEST PHARMACEUTICAL SERVICES INC is a leading global manufacturer specializing in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The company's offerings include primary proprietary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, alongside contract manufacturing, analytical lab services, and integrated solutions. Its customer base comprises leading biologic, generic, pharmaceutical, diagnostic, and medical device companies worldwide. The company operates through two global business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment provides elastomers & primary containment, drug delivery devices, integrated systems, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. This segment's packaging products include stoppers and seals for injectable packaging systems, designed to ensure drug compatibility and stability while supporting operational efficiency. It also offers syringe and cartridge components, including custom solutions for injectable drug applications, and administration systems that enhance safe drug delivery through advanced reconstitution, mixing, and transfer technologies. The company also provides films, coatings, washing, vision inspection, and sterilization processes and services to improve product quality and mitigate contamination and compatibility risks. This segment's portfolio also features drug containment solutions such as vials, syringes, plungers, and cartridges, which offer high-quality alternatives to address glass incompatibility and cold storage challenges, reducing breakage risk. Additionally, it offers various self-injection devices for at-home delivery of injectable therapies.

West Pharmaceutical Services, Inc. (NYSE:WST) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for WST at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-29, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for WST spans 10-Q, 8-K, 8-K/A, DEF 14A.

Recent high-impact activity:

  • West 10-Q Details Q3 Beat: $874.5M Sales, $3.02 EPS, $685M Buyback
  • West Pharma Beats Q3, Lifts FY26 EPS Guidance to $9.38-$9.48 and Sales to $3.41B-$3.42B
  • West Pharma Lifts FY EPS Outlook to $9.38-$9.48 After Q3 Beat
  • West Pharma Guides FY Adjusted EPS to $9.38-$9.48
  • West Pharmaceutical Reports Strong Q2 Results, Details Cyber Incident Impact, and Boosts Share Buybacks

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$3.07B
Net Income
$493.7M
Diluted EPS
$6.79
Op. Cash Flow
$754.8M
Free Cash Flow
$468.9M
Gross Profit
$1.1B
Operating Income
$584.9M
Cash & Equivalents
$791.3M
Total Debt
$202.8M
Debt / Equity
0.06×
Net Margin
16.1%
Shares Outstanding
72M sh
Source: 10-K · filed 2026-02-17 · accession 0000105770-26-000010

Short Interest & Short Volume

2.34 days to cover

FINRA reported short interest of 1,807,517 shares in WST as of the October 30, 2026 settlement, a 10.2% decrease from the prior period — about 2.3 days to cover at its recent average daily volume. On November 20, 2026, 48.5% of WST volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,807,517 shares as of October 30, 2026
Change vs prior period▼ 10.2%
Days to cover2.34 at avg daily volume of 774,083
Daily short volume (FINRA facilities)48.5% of 193,557 shares on November 20, 2026
5-day average short volume45.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with W →
$390.3
52-week range · as of 2026-10-29 $223.83 – $438.27
Market cap
$27.19B
Volume
623.5K (0.9× avg)
3-mo avg 685.3K
Live data · 2026-11-21 11:14 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed WST - Latest Insights

WST
Oct 29, 2026, 4:17 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $416.67
Real-time Price: $390.30 info
Change: -$26.37 (-6%) info
Market Cap: $27.189B info
WST
Oct 29, 2026, 7:06 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $410.95
Real-time Price: $390.30 info
Change: -$20.65 (-5%) info
Market Cap: $27.189B info
WST
Oct 29, 2026, 7:04 AM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $410.95
Real-time Price: $390.30 info
Change: -$20.65 (-5%) info
Market Cap: $27.189B info
WST
Oct 29, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $398.00
Real-time Price: $390.30 info
Change: -$7.70 (-2%) info
Market Cap: $27.189B info
WST
Jul 23, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $354.08
Real-time Price: $390.30 info
Change: +$36.22 (+10%) info
Market Cap: $27.189B info
WST
Jul 23, 2026, 7:14 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $380.00
Real-time Price: $390.30 info
Change: +$10.30 (+3%) info
Market Cap: $27.189B info
WST
Jul 23, 2026, 6:34 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $360.20
Real-time Price: $390.30 info
Change: +$30.10 (+8%) info
Market Cap: $27.189B info
WST
Jul 23, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $360.20
Real-time Price: $390.30 info
Change: +$30.10 (+8%) info
Market Cap: $27.189B info
WST
Jun 01, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $316.75
Real-time Price: $390.30 info
Change: +$73.55 (+23%) info
Market Cap: $27.189B info
WST
May 20, 2026, 4:04 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $305.50
Real-time Price: $390.30 info
Change: +$84.80 (+28%) info
Market Cap: $27.189B info
WST
May 11, 2026, 5:41 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $315.00
Real-time Price: $390.30 info
Change: +$75.30 (+24%) info
Market Cap: $27.189B info
WST
May 11, 2026, 5:06 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $315.00
Real-time Price: $390.30 info
Change: +$75.30 (+24%) info
Market Cap: $27.189B info
WST
Apr 23, 2026, 4:12 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $309.70
Real-time Price: $390.30 info
Change: +$80.60 (+26%) info
Market Cap: $27.189B info
WST
Apr 23, 2026, 10:56 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $313.01
Real-time Price: $390.30 info
Change: +$77.29 (+25%) info
Market Cap: $27.189B info
WST
Apr 23, 2026, 7:11 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $325.01
Real-time Price: $390.30 info
Change: +$65.29 (+20%) info
Market Cap: $27.189B info
WST
Apr 23, 2026, 6:22 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $283.99
Real-time Price: $390.30 info
Change: +$106.31 (+37%) info
Market Cap: $27.189B info
WST
Apr 23, 2026, 6:03 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $283.99
Real-time Price: $390.30 info
Change: +$106.31 (+37%) info
Market Cap: $27.189B info
WST
Mar 12, 2026, 8:31 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $238.25
Real-time Price: $390.30 info
Change: +$152.05 (+64%) info
Market Cap: $27.189B info
WST
Mar 09, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $248.06
Real-time Price: $390.30 info
Change: +$142.24 (+57%) info
Market Cap: $27.189B info
WST
Feb 17, 2026, 4:28 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $243.19
Real-time Price: $390.30 info
Change: +$147.11 (+60%) info
Market Cap: $27.189B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets